Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.

Podcast by Dr. Camidge on ALK Rearrangements and a New Era of Molecular Oncology
Fri, 02/26/2010 - 14:46
Author
Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

Last week, Dr. Ross Camidge from the University of Colorado joined me on a webinar entitled "One Size Does Not Fit All" in which he discussed the early work on ALK rearrangements and the novel agent PF-02341066 (now known as crizotinib) in particular, and the new era of molecularly defined practice of oncology in particular. This story has been widely considered to be among the most important in the field of lung cancer over the last few years, and Dr. Camidge did not disappoint.

Not only did many of the participants in the live program write comments here expressing their positive feedback on the great energy and overall quality of the program, but both our transcriber and the editor of our podcasts independently commented to me that they thought it was a terrific podcast and that they learned a lot (and they don't have a special, vested interest in lung cancer issues).

Here's the audio and video podcast links, as well as the transcript and the figures from the webinar:

[powerpress]

dr-camidge-on-alk-inhibitors-and-molecular-oncology-audio-podcast

dr-camidge-on-alk-inhibitors-and-molecular-oncology-transcript

dr-camidge-on-alk-inhibitors-and-molecular-oncology-figures

Finally, I'd like to personalize this a bit, because one of the people who was mentioned in the podcast, Andy Hill, has also been featured in the local news in both Seattle (link to news report here) and Denver (link here) as a remarkable example of the promise of molecular oncology. He's also been a dedicated and extremely helpful supporter of GRACE in terms of both financial support and participating in our recent programs and some meetings as we work on the future directions for our organization. So I'd like to dedicate the program to Andy and hope he continues to redefine the great success of this work in how well he does.

Speaking of which, we could really benefit from your support for these programs. This webinar wasn't from a grant but rather from your contributions. I hope you find these activities helpful and will support them. I'd also encourage people to tell others, provide the link, if you know of anyone else who might benefit from learning the material in our educational programs. We'd hate to think of the Andy Hills out there who may miss a chance for a very helpful treatment because they simply didn't know such a possibility might exist. And unfortunately, many oncologists are still not aware of these developments: the field is simply moving too quickly.

Comments or questions? We'd love to get your feedback.

Next Previous link

Previous PostNext Post

Related Content

Forum Discussions

Hi szhang, I'm so sorry to know that your father is in this position.


It's not known if your father would have progressed in the same way whether he stayed on...

Hi Janine, thank you so much for your kind response. It definitely brought some clarity during this uncertain time for my father. He's scheduled for the first infusion next Tuesday with...

Hi snickerdoodle, I'm sorry you're going through this worry. Cea levels for nsclc don't really inform treatment decisions. They sometimes forewarn the coming of progression but sometimes progression doesn't follow a...

I appreciate the comments. I also want to correct my mistake in CEA level- I forgot the decimal. In the past year, my level has increased from 4.7 to 28.3, NOT...

Hi Rick and welcome to Grace. I'm sorry you're going through this. Ethically or legally we can't comment on reports.
Cancer and infection look alike on film and they both cause...

I just saw this link on our fb page. Scanxiety is unfortunately real enough to have a term everyone knows.  Cancer or no (and I'm going for no) you can use...

Recent Comments

JOIN THE CONVERSATION
2nd Opinion and Update
By szhang123 on Wed, 06/29/2022 - 15:26
Hi szhang, I'm so sorry to…
By szhang123 on Wed, 06/29/2022 - 14:09
CEA 28.3
By snickerdoodle531 on Wed, 06/22/2022 - 16:05
Hi snickerdoodle, I'm sorry…
By snickerdoodle531 on Wed, 06/22/2022 - 10:52